News & Analysis as of

Congressional Investigations & Hearings Public Health

Holland & Knight LLP

Holland & Knight Health Dose: July 15, 2025

Holland & Knight LLP on

The U.S. House of Representatives returns from a district work period. The U.S. Senate is expected to consider the $9.4 billion rescissions package that passed the House last month. If not passed by July 18, 2025, the...more

Holland & Knight LLP

Holland & Knight Health Dose: March 4, 2025

Holland & Knight LLP on

Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector....more

Holland & Knight LLP

Holland & Knight Health Dose: February 25, 2025

Holland & Knight LLP on

Holland & Knight Health Dose Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector....more

Holland & Knight LLP

Holland & Knight Health Dose: January 21, 2025

Holland & Knight LLP on

Holland & Knight Health Dose Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector....more

Holland & Knight LLP

Senate Committee Convenes Hearing to Examine PFAS as Hazardous Substances

Holland & Knight LLP on

The U.S. Environmental Protection Agency (EPA) issued a proposed rule on Sept. 6, 2022, to designate perfluorooctanoic acid (PFOA) and perfluorooctane sulfonic acid (PFOS), along with their structural isomers, as hazardous...more

Holland & Knight LLP

Holland & Knight Health Dose: March 19, 2024

Holland & Knight LLP on

Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector....more

Holland & Knight LLP

Holland & Knight Health Dose: March 5, 2024

Holland & Knight LLP on

Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector. ...more

Hogan Lovells

Coronavirus: The Hill and the Headlines – COVID-19 D.C. Update – September 2020 # 10

Hogan Lovells on

In Washington - On Friday, the CDC reversed its guidance advising that it was unnecessary to test people without symptoms of COVID-19. The change came after it was revealed that CDC scientists did not write it. The...more

WilmerHale

Weekly COVID-19 Oversight & Enforcement Report

WilmerHale on

The House Select Subcommittee on the Coronavirus Crisis held a briefing on racial health disparities in the coronavirus crisis. Participants explained that communities of color have been disproportionately impacted by the...more

Wilson Sonsini Goodrich & Rosati

FDA's COVID-19 Test Kit Policy Shortsighted and Creates Unacceptable Industry Confusion

In recent days, the U.S. Food and Drug Administration's (FDA's) policy granting authorization to manufacturers and laboratories for desperately-needed COVID-19 test kits has created mass confusion and even led to the...more

McDermott Will & Emery

FDA Update: COVID-19 Testing, Vaccine Development and Other Impacts

McDermott Will & Emery on

In response to the United States’ rapidly evolving public health situation, the US Food and Drug Administration (FDA) recently released guidance on high-complexity in vitro diagnostic (IVD) tests for COVID-19. This article...more

Holland & Knight LLP

Congressional Democrats Consider Paid Sick Leave Amid COVID-19 Outbreak

Holland & Knight LLP on

The U.S. House of Representatives' Committee on Education and Labor on March 11, 2020, held a hearing on The Healthy Families Act (H.R. 1784). The bill, which was introduced in early 2019, requires employers to provide at...more

Robins Kaplan LLP

Financial Daily Dose 3.11.2020 | Top Story: New Wells Fargo CEO Scharf emerges unscathed after House testimony

Robins Kaplan LLP on

Wells Fargo’s latest CEO, Charles Scharf—the bank’s third chief in the past four years—faced a hostile but less pitchfork-and-torch wielding House Financial Services Committee hearing on Tuesday, distancing himself from his...more

Robins Kaplan LLP

Financial Daily Dose 3.10.2020 | Top Story: US Markets Dive Again in Worst Trading Day Since 2008

Robins Kaplan LLP on

Monday on Wall Street was the equivalent of a well-forecast storm that still managed to blow meteorologists’ minds. The deadly combination of diving oil prices and yet more COVID-19 worries spelled disaster for U.S. markets,...more

Mintz - Health Care Viewpoints

FDA User Fees: How Do They Work?

Nearly 30 years ago, the first law authorizing the Food and Drug Administration (FDA) to collect fees from drug manufacturers to expedite the review of new prescription drug applications was enacted. Since then, additional...more

Patrick Malone & Associates P.C. | DC Injury...

Investigations rip FDA for laxity on asbestos-tainted talc and medical devices

When it comes to medical products — devices put in or substances put on our bodies — consumers may be ill-served by the federal regulators who are supposed to protect them from injury....more

King & Spalding

Senate Bipartisan Discussion Draft Released to Lower Health Care Costs, Address Surprise Billing

King & Spalding on

On May 23, 2019, Senate Health, Education, Labor, and Pensions (HELP) Committee Chairman Lamar Alexander (R-TN) and Patty Murray (D-WA) released the Lower Health Care Costs Act of 2019 – bipartisan draft legislation to reduce...more

Mintz - Health Care Viewpoints

Senators to Receive Update on Biosimilar Implementation from CDER’s Woodcock

On September 17, 2015, members of the Senate Health, Education, Labor & Pensions (HELP) Committee will have an opportunity to hear from and question Dr. Janet Woodock, the director of FDA’s Center for Drug Evaluation and...more

Mintz - ML Strategies

Africa Update - July 2015 #4

Mintz - ML Strategies on

Leading the News - Burundi: On July 19th, representatives of the Burundian Government failed to appear for talks backed by the East African Community (EAC) aimed at ending the unrest caused by President Pierre...more

19 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide